NCT00397020View on ClinicalTrials.gov

Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapine for Adults With Acute Mania or Mixed Episodes

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Bipolar Disorder
Interventions
DRUG

divalproex ER

Dose: 30mg per kg, rounded to nearest 500mg, dosed PO QHS. Adjustments made through trial to obtain serum valproic acid levels of 85-125 mcg/ml

DRUG

quetiapine

Dose: 200mg PO QHS, titrated up to therapeutic dose of 600-800mg.

Trial Locations (1)

92103

UCSD Medical Center, San Diego

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

University of California, San Diego

OTHER

NCT00397020 - Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapine for Adults With Acute Mania or Mixed Episodes | Biotech Hunter | Biotech Hunter